Category: Chronic Hepatitis B Virus

  • Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

    Shots: The companies plan to initiate a P-II study assessing selgantolimod + VIR-2218 in treatment-experienced and treatment-naïve people living with HBV. People in the trial with HBV treatment experience may also receive Gilead’s Vemlidy The 1EPs of the study will be the proportion of patients achieving a functional cure, defined as an off-therapy loss of […]